The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology.
Open accessAbstract
Hypervascularity, focal necrosis, persistent cerebral edema, and rapid cellular proliferation are key histopathologic features of glioblastoma multiforme (GBM), the most common and malignant of human brain tumors. By immunoperoxidase and immunofluorescence, we definitively have demonstrated the presence of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFr) in five out of five human glioma cell lines (U-251MG, U-105MG, D-65MG, D-54MG, and CH-235MG) and in eight human GBM tumor surgical specimens. In vitro experiments with glioma cell lines revealed a consistent and reliable relation between EGFr activation and VEGF production; namely, EGF (1-20 ng/ml) stimulation of glioma cells resulted in a 25-125% increase in secretion of bioactive VEGF. Conditioned media (CM) prepared from EGF-stimulated glioma cell lines produced significant increases in cytosolic free intracellular concentrations of Ca2+ ([Ca2+]i) in human umbilical vein endothelial cells (HUVECs). Neither EGF alone or CM from glioma cultures prepared in the absence of EGF induced [Ca2+]i increases in HUVECs. Preincubation of glioma CM with A4.6.1, a monoclonal antibody to VEGF, completely abolished VEGF-mediated [Ca2+]i transients in HUVECs. Likewise, induction by glioma-derived CM of von Willebrand factor release from HUVECs was completely blocked by A4.6.1 pretreatment. These observations provide a key link in understanding the basic cellular pathophysiology of GBM tumor angiogenesis, increased vascular permeability, and cellular proliferation. Specifically, EGF activation of EGFr expressed on glioma cells leads to enhanced secretion of VEGF by glioma cells. VEGF released by glioma cells in situ most likely accounts for pathognomonic histopathologic and clinical features of GBM tumors in patients, including striking tumor angiogenesis, increased cerebral edema and hypercoagulability manifesting as focal tumor necrosis, deep vein thrombosis, or pulmonary embolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
Grynkiewicz, G., Poenie, M., & Tsien, R. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83641-4 · Cited by 21,607
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V, & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,866
In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain
Chen, T. R. (1977) · Experimental Cell Research · doi:10.1016/0014-4827(77)90089-1 · Cited by 1,700
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Structural Characterization and Biological Functions of Fibroblast Growth Factor
GOSPODAROWICZ, D., FERRARA, N., SCHWEIGERER, L., & NEUFELD, G. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-2-95 · Cited by 1,273
Anti-Angiogenesis: New Concept for Therapy of Solid Tumors
Folkman, J. (1972) · Annals of Surgery · doi:10.1097/00000658-197203000-00014 · Cited by 1,171
Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells
Fett, J. W., Strydom, D. J., Lobb, R. R., Alderman, E. M., Bethune, J. L., Riordan, J. F., & Vallee, B. L. (1985) · Biochemistry · doi:10.1021/bi00341a030 · Cited by 923
Transforming Growth Factor-α: a More Potent Angiogenic Mediator than Epidermal Growth Factor
Schreiber, A. B., Winkler, M. E., & Derynck, R. (1986) · Science · doi:10.1126/science.2422759 · Cited by 838
Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Pan, Y. C., Olander, J. V., Connolly, D. T., & Stern, D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1535 · Cited by 835
LONG TERM CULTURE OF NORMAL AND NEOPLASTIC HUMAN GLIA
PONTÉN, J., & MACINTYRE, E. H. (1968) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1968.tb03502.x · Cited by 720
Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W., & Heldin, C.-H. (1989) · Nature · doi:10.1038/338557a0 · Cited by 711
The vascular endothelial growth factor family of polypeptides
Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J., & Leung, D. W. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240470305 · Cited by 641
BIGNER, D. D., BIGNER, S. H., PONTÉN, J., WESTERMARK, B., MAHALEY, M. S., RUOSLAHTI, E., HERSCHMAN, H., ENG, L. F., & WIKSTRAND, C. J. (1981) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198105000-00001 · Cited by 480
Patient age, histologic features, and length of survival in patients with glioblastoma multiforme
Burger, P. C., & Green, S. B. (1987) · Cancer · doi:10.1002/1097-0142(19870501)59:9<1617::aid-cncr2820590916>3.0.co;2-x · Cited by 391
Brock, T. A., Dvorak, H. F., & Senger, D. R. (1991) · PubMed · Cited by 321
Self-citationVascular permeability factor: A unique regulator of blood vessel function
Connolly, D. T. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240470306 · Cited by 317
Kim, K. J., Li, B., Houck, K., Winer, J., & Ferrara, N. (1992) · Growth Factors · doi:10.3109/08977199209023937 · Cited by 306
Conn, G., Soderman, D. D., Schaeffer, M. T., Wile, M., Hatcher, V. B., & Thomas, K. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1323 · Cited by 222
Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.
Zagzag, D., Miller, D. C., Sato, Y., Rifkin, D. B., & Burstein, D. (1990) · PubMed · Cited by 162
Properties of human malignant glioma cells in vitro.
Pontén, J., & Westermark, B. (1978) · PubMed · Cited by 151
The Effects of Platelet-Derived Growth Factor in Cultured Microvessel Endothelial Cells*
Bar, R. S., Boes, M. A., Booth, B. A., Dake, B. L., Henley, S. A., & HART, M. N. (1989) · Endocrinology · doi:10.1210/endo-124-4-1841 · Cited by 133
Maxwell, M., Naber, S. P., Wolfe, H. J., Hedley‐Whyte, E. T., Galanopoulos, T., Neville-Golden, J., & Antoniades, H. N. (1991) · PubMed · Cited by 113
Boström, S., Holmgren, E., Jonsson, O., Lindberg, S., Lindström, B., Winsö, I., & Zachrisson, B. E. (1986) · Acta Neurochirurgica · doi:10.1007/bf01812279 · Cited by 90
Interleukin-1β induction of tumor necrosis factor-alpha gene expression in human astroglioma cells
Bethea, J. R., Chung, Y., Sparacio, S. M., Gillespie, G. Y., & Benveniste, E. N. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90049-q · Cited by 76
Self-citationCriscuolo, G. R., Lelkes, P. I., Rotrosen, D., & Oldfield, E. H. (1989) · Journal of neurosurgery · doi:10.3171/jns.1989.71.6.0884 · Cited by 62
Interleukin‐1β induction of TNF‐α gene expression: Involvement of protein kinase C
Bethea, J. R., Gillespie, G. Y., & Benveniste, E. N. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041520207 · Cited by 57
Self-citationBethea, J. R., Gillespie, G. Y., Chung, I. ^., & Benveniste, E. N. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90047-q · Cited by 57
Self-citationResponse of microvascular endothelial cells to biological response modifiers
Hicks, C., Breit, S., & Penny., R. (1989) · Immunology and Cell Biology · doi:10.1038/icb.1989.41 · Cited by 27
Tuomela, T. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90494-c · Cited by 15
Cited by
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Epidermal growth factor-related peptides and their receptors in human malignancies
Salomon, D. S., Brandt, R., Ciardiello, F., & Normanno, N. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00144-i · Cited by 2,690
Herbst, R. S., Giaccone, G., Schiller, J. H., Natale, R. B., Miller, V., Manegold, C., Scagliotti, G., Rosell, R., Oliff, I., Reeves, J. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.215 · Cited by 1,707
Review of epidermal growth factor receptor biology
Herbst, R. S. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.11.041 · Cited by 1,390
Malignant glioma: genetics and biology of a grave matter
Maher, E. A., Furnari, F. B., Bachoo, R. M., Rowitch, D. H., Louis, D. N., Cavenee, W. K., & DePinho, R. A. (2001) · Genes & Development · doi:10.1101/gad.891601 · Cited by 1,229
Metadata
- Authors
- Goldman, C. K., Kim, J., Wong, W. L., King, V, Brock, T., & Gillespie, G. Y.
- Venue
- Molecular Biology of the Cell
- Published
- 1993-01
- Volume
- 4
- Issue
- 1
- Pages
- 121-133
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- OpenAlex
- W2133138712
- Cited by
- 531
- References
- 31
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.